Origo Biopharma is a pharmaceutical company focused on the research and development of novel therapeutic products that modulate the immune system in order to obtain new treatments against diseases with an important immuno-inflammatory component such as cancer and fibrosis. Our activity focuses on the discovery of new drugs that cover the needs of more effective treatments for these diseases. Our mission is to discover and develop next-generation organ selective therapeutic products .